| 臺大學術典藏 |
2020-05-25T06:52:05Z |
NF-�eB p50 promotes tumor cell invasion through negative regulation of invasion suppressor gene CRMP-1 in human lung adenocarcinoma cells
|
Cheng A.-L.;Kuo M.-L;Chang W.C;Yen-Shen Lu;Yeh P.Y;Gao M; Gao M; Yeh P.Y; YEN-SHEN LU; Chang W.C; Kuo M.-L; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:05Z |
The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers
|
Chang K.-J.;Yen-Shen Lu;Lin C.-H;Shen C.-Y;You S.-L;Yang S.-Y;Lien H.-C;Kuo S.-H;Huang C.-S; Huang C.-S; Kuo S.-H; Lien H.-C; Yang S.-Y; You S.-L; Shen C.-Y; Lin C.-H; YEN-SHEN LU; Chang K.-J. |
| 臺大學術典藏 |
2020-05-25T06:52:05Z |
FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein kinase C �_ signaling
|
Chen C.-S.;Cheng A.-L;Byrd J.C;Muthusamy N;Kulp S.K;Wang D.-S;Ma Y.-H;Wang Y.-C;Yen-Shen Lu;Hung J.-H; Hung J.-H; YEN-SHEN LU; Wang Y.-C; Ma Y.-H; Wang D.-S; Kulp S.K; Muthusamy N; Byrd J.C; Cheng A.-L; Chen C.-S. |
| 臺大學術典藏 |
2020-05-25T06:52:04Z |
Molecular subtypes of breast cancer emerging in young women in Taiwan: Evidence for more than just westernization as a reason for the disease in Asia
|
Cheng A.-L.;Chang K.-J;Kuo W.-H;Liu J.M;Lan C;Kuo S.-H;Shen Y.-C;Kuo K.-T;Lee W.-C;Huang C.-S;Yen-Shen Lu;Liau J.-Y;Lin C.-H; Lin C.-H; Liau J.-Y; YEN-SHEN LU; Huang C.-S; Lee W.-C; Kuo K.-T; Shen Y.-C; Kuo S.-H; Lan C; Liu J.M; Kuo W.-H; Chang K.-J; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:04Z |
Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway
|
Chen P.-J; Cheng A.-L.; Hsieh H.-P; YEN-SHEN LU; Hsu C.-H; Hsu C; Yeh P.-Y; Cheng A.-L.;Chen P.-J;Hsieh H.-P;Yen-Shen Lu;Hsu C.-H;Hsu C;Yeh P.-Y;Chen K.-F; Chen K.-F |
| 臺大學術典藏 |
2020-05-25T06:52:04Z |
OSU-03012, a novel celecoxib derivative, induces reactive oxygen species-related autophagy in hepatocellular carcinoma
|
Cheng A.-L.;Kuo M.-L;Chen C.-S;Feng W.-C;Lee W.-C;Chen K.-F;Hsu C.-H;Yen-Shen Lu;Yeh P.Y;Gao M; Gao M; Yeh P.Y; YEN-SHEN LU; Hsu C.-H; Chen K.-F; Lee W.-C; Feng W.-C; Chen C.-S; Kuo M.-L; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:04Z |
Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma
|
Cheng A.-L.;Hsu C;Yen-Shen Lu;Wang D.-S;Fan H.-H;Yu S.-L;Liou J.-Y;Liang J.-D;Shen Y.-C;Ou D.-L; Ou D.-L; Shen Y.-C; Liang J.-D; Liou J.-Y; Yu S.-L; Fan H.-H; Wang D.-S; YEN-SHEN LU; Hsu C; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:03Z |
Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin
|
Cheng A.-L.; Lin C.-H; Chang K.-J; Kuo W.-H; Hsu C; Lee W.-C; Liau J.-Y; Huang C.-S; Shao Y.-Y;Kuo K.-T;Hu F.-C;Yen-Shen Lu;Huang C.-S;Liau J.-Y;Lee W.-C;Hsu C;Kuo W.-H;Chang K.-J;Lin C.-H;Cheng A.-L.; Shao Y.-Y; Kuo K.-T; Hu F.-C; YEN-SHEN LU |
| 臺大學術典藏 |
2020-05-25T06:52:03Z |
Locoregional therapy improves survival for metastatic breast cancer patients? Benefit remains questionable!
|
Yen-Shen Lu;Lin C.-H;Chang D.-Y; Chang D.-Y; Lin C.-H; YEN-SHEN LU |
| 臺大學術典藏 |
2020-05-25T06:52:03Z |
Management of HER2-positive breast cancer in Asia: consensus statement from the Asian Oncology Summit 2009
|
Pritchard K.I.;Shao Z.-M;Voravud N;Yen-Shen Lu;Yip C.H;Ang P.T;Khoo K.S;Anderson B.O;Wong N.S; Wong N.S; Anderson B.O; Khoo K.S; Ang P.T; Yip C.H; YEN-SHEN LU; Voravud N; Shao Z.-M; Pritchard K.I. |
| 臺大學術典藏 |
2020-05-25T06:52:02Z |
Unique features of breast cancer in Asian women-Breast cancer in Taiwan as an example
|
Huang C.-S;Lin C.-H;Yen-Shen Lu;Shen C.-Y.; Huang C.-S; Lin C.-H; YEN-SHEN LU; Shen C.-Y. |
| 臺大學術典藏 |
2020-05-25T06:52:02Z |
O6-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancers
|
Wu P.-F;Kuo K.-T;Kuo L.-T;Lin Y.-T;Lee W.-C;Yen-Shen Lu;Yang C.-H;Wu R.-M;Tu Y.-K;Tasi J.-C;Tseng H.-M;Tseng S.-H;Cheng A.-L;Lin C.-H.; Wu P.-F; Kuo K.-T; Kuo L.-T; Lin Y.-T; Lee W.-C; YEN-SHEN LU; Yang C.-H; Wu R.-M; Tu Y.-K; Tasi J.-C; Tseng H.-M; Tseng S.-H; Cheng A.-L; Lin C.-H. |
| 臺大學術典藏 |
2020-05-25T06:52:01Z |
Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma
|
Chiang C.-T;Yeh P.-Y;Gao M;Chen C.-W;Yeh L.-C;Feng W.-C;Kuo S.-H;Hsu C.-H;Yen-Shen Lu;Cheng A.-L.; Chiang C.-T; Yeh P.-Y; Gao M; Chen C.-W; Yeh L.-C; Feng W.-C; Kuo S.-H; Hsu C.-H; YEN-SHEN LU; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:01Z |
Management of ErbB2-positive breast cancer: Insights from preclinical and clinical studies with lapatinib
|
Vogel C;Chan A;Gril B;Kim S.-B;Kurebayashi J;Liu L;Yen-Shen Lu;Moon H.; Vogel C; Chan A; Gril B; Kim S.-B; Kurebayashi J; Liu L; YEN-SHEN LU; Moon H. |
| 臺大學術典藏 |
2020-05-25T06:52:01Z |
The prevalence and assessment of ErbB2-positive breast cancer in Asia: A literature survey
|
Tan Y.O;Han S;Yen-Shen Lu;Yip C.-H;Sunpaweravong P;Jeong J;Caguioa P.B;Aggarwal S;Yeoh E.M;Moon H.; Tan Y.O; Han S; YEN-SHEN LU; Yip C.-H; Sunpaweravong P; Jeong J; Caguioa P.B; Aggarwal S; Yeoh E.M; Moon H. |
| 臺大學術典藏 |
2020-05-25T06:52:00Z |
I�eB kinases increase Myc protein stability and enhance progression of breast cancer cells
|
Yeh P.-Y;Yen-Shen Lu;Ou D.-L;Cheng A.-L.; Yeh P.-Y; YEN-SHEN LU; Ou D.-L; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:00Z |
Cisplatin as an active treatment in zoledronate-refractory hypercalcemia
|
Lin P.-H;Chiu C.-F;Yen-Shen Lu; Lin P.-H; Chiu C.-F; YEN-SHEN LU |
| 臺大學術典藏 |
2020-05-25T06:52:00Z |
Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001
|
Kuo S.-H;Hsu C.-H;Chen L.-T;Yen-Shen Lu;Lin C.-H;Yeh P.-Y;Jeng H.-J;Gao M;Yeh K.-H;Cheng A.-L.; Kuo S.-H; Hsu C.-H; Chen L.-T; YEN-SHEN LU; Lin C.-H; Yeh P.-Y; Jeng H.-J; Gao M; Yeh K.-H; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:00Z |
The Association of Infrared Imaging Findings of the Breast with Hormone Receptor and Human Epidermal Growth Factor Receptor 2 Status of Breast Cancer
|
Wang J;Shih T.T.F;Yen R.-F;Yen-Shen Lu;Chen C.-Y;Mao T.-L;Lin C.-H;Kuo W.-H;Tsai Y.-S;Chang K.-J;Chien K.-L.; Wang J; Shih T.T.F; Yen R.-F; YEN-SHEN LU; Chen C.-Y; Mao T.-L; Lin C.-H; Kuo W.-H; Tsai Y.-S; Chang K.-J; Chien K.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:00Z |
Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer
|
Yen-Shen Lu;Chen D.-R;Tseng L.-M;Yeh D.-C;Chen S.-T;Hsieh C.-M;Wang H.-C;Yeh H.-T;Kuo S.-H;Huang C.-S.; YEN-SHEN LU; Chen D.-R; Tseng L.-M; Yeh D.-C; Chen S.-T; Hsieh C.-M; Wang H.-C; Yeh H.-T; Kuo S.-H; Huang C.-S. |
| 臺大學術典藏 |
2020-05-25T06:51:59Z |
Prognostic molecular markers in Women aged 35 years or younger with breast cancer: Is there a difference from the older patients?
|
Lin C.-H;Yen-Shen Lu;Huang C.-S;Kuo K.-T;Wang C.-C;You S.-L;Lin P.-H;Chang D.-Y;Kuo W.-H;Chang K.-J;Cheng A.-L.; Lin C.-H; YEN-SHEN LU; Huang C.-S; Kuo K.-T; Wang C.-C; You S.-L; Lin P.-H; Chang D.-Y; Kuo W.-H; Chang K.-J; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:51:59Z |
Axillary vs sentinel lymph node dissectionfor invasive breast cancer [2]
|
Chen I.-C;Lin C.-H;Yen-Shen Lu; Chen I.-C; Lin C.-H; YEN-SHEN LU |
| 臺大學術典藏 |
2020-05-25T06:51:59Z |
Multimodel assessment of BRCA1 mutations in Taiwanese (ethnic Chinese) women with early-onset, bilateral or familial breast cancer
|
Chang K.-J.;Hwu W.-L;Hsieh F.-J;Cheng A.-L;Lin C.-H;Sargeant A.M;Bai L.-Y;Yen-Shen Lu;Liu T.-P;Chien Y.-H;Huang A.-C;Lin P.-H;Kuo W.-H; Kuo W.-H; Lin P.-H; Huang A.-C; Chien Y.-H; Liu T.-P; YEN-SHEN LU; Bai L.-Y; Sargeant A.M; Lin C.-H; Cheng A.-L; Hsieh F.-J; Hwu W.-L; Chang K.-J. |
| 臺大學術典藏 |
2020-05-25T06:51:58Z |
The emerging epidemic of estrogen-related cancers in young women in a developing Asian country
|
Cheng A.-L.;You S.-L;Lai M.-S;Cheng W.-F;Huang C.-S;Kuo K.-T;Yen-Shen Lu;Chiang C.-J;Chen Y.-C;Lin C.-H; Lin C.-H; Chen Y.-C; Chiang C.-J; YEN-SHEN LU; Kuo K.-T; Huang C.-S; Cheng W.-F; Lai M.-S; You S.-L; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:51:58Z |
The impact of diabetes mellitus on prognosis of early breast cancer in Asia
|
Lai M.-S.;Cheng A.-L;Kuo R.N.C;Chen H.-M;Yen-Shen Lu;Lin Z.-Z;Shau W.-Y;Shao Y.-Y;Chen W.-W; Chen W.-W; Shao Y.-Y; Shau W.-Y; Lin Z.-Z; YEN-SHEN LU; Chen H.-M; Kuo R.N.C; Cheng A.-L; Lai M.-S. |
| 臺大學術典藏 |
2020-05-25T06:51:58Z |
Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinoma
|
Cheng A.-L.;Hsu C.-H;Shen Y.-C;Huang C.-C;Yen-Shen Lu;Hsiao C.-H;Lee K.-D;Hsu C;Lin Z.-Z;Shao Y.-Y; Shao Y.-Y; Lin Z.-Z; Hsu C; Lee K.-D; Hsiao C.-H; YEN-SHEN LU; Huang C.-C; Shen Y.-C; Hsu C.-H; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:51:57Z |
Differential expression of moesin in breast cancers and its implication in epithelial-mesenchymal transition
|
Lien H.-C.;Yao Y.-T;Chen J.-W;Yen-Shen Lu;Liau J.-Y;Wang C.-C; Wang C.-C; Liau J.-Y; YEN-SHEN LU; Chen J.-W; Yao Y.-T; Lien H.-C. |
| 臺大學術典藏 |
2020-05-25T06:51:57Z |
Radiosensitizing effect of a phenylbutyrate-derived histone deacetylase inhibitor in hepatocellular carcinoma
|
Cheng J.C.-H.; Kulp S.K; Cheng A.-L; Cheng J.C.-H.;Kulp S.K;Cheng A.-L;Gao M;Tzen K.-Y;Chou C.-H;Yen-Shen Lu; YEN-SHEN LU; Chou C.-H; Tzen K.-Y; Gao M |
| 臺大學術典藏 |
2020-05-25T06:51:57Z |
Hashimoto's encephalopathy as the cause of deteriorating consciousness during treatment of leptomeningeal carcinomatosis from breast cancer
|
Liang Y.-H; Wu P.-F; Lin C.-H; YEN-SHEN LU; Yen-Shen Lu;Lin C.-H;Wu P.-F;Liang Y.-H |
| 臺大學術典藏 |
2020-05-25T06:51:56Z |
Differential expression of ubiquitin carboxy-terminal hydrolase L1 in breast carcinoma and its biological significance
|
Yao Y.-T.; Lien H.-C;Wang C.-C;Lin C.-H;Yen-Shen Lu;Huang C.-S;Hsiao L.-P;Yao Y.-T.; Lien H.-C; Wang C.-C; Lin C.-H; YEN-SHEN LU; Huang C.-S; Hsiao L.-P |
| 臺大學術典藏 |
2020-05-25T06:51:56Z |
Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomas
|
Wu P.-F;Huang W.-C;Yang J.C.-H;Yen-Shen Lu;Shih J.-Y;Wu S.-G;Lin C.-H;Cheng A.-L.; Wu P.-F; Huang W.-C; Yang J.C.-H; YEN-SHEN LU; Shih J.-Y; Wu S.-G; Lin C.-H; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:51:56Z |
Clinical significance of ESR1 gene copy number changes in breast cancer as measured by fluorescence in situ hybridisation
|
Lin C.-H;Liu J.M;Yen-Shen Lu;Lan C;Lee W.-C;Kuo K.-T;Wang C.-C;Chang D.-Y;Huang C.-S;Cheng A.L.; Lin C.-H; Liu J.M; YEN-SHEN LU; Lan C; Lee W.-C; Kuo K.-T; Wang C.-C; Chang D.-Y; Huang C.-S; Cheng A.L. |
| 臺大學術典藏 |
2020-05-25T06:51:56Z |
The first two lines of chemotherapy for anthracycline-naive metastatic breast cancer: A comparative study of the efficacy of anthracyclines and non-anthracyclines
|
Chen W.-W;Chang D.-Y;Huang S.-M;Lin C.-H;Hsu C;Lin M.-H;Huang C.-S;Yen-Shen Lu;Cheng A.-L.; Chen W.-W; Chang D.-Y; Huang S.-M; Lin C.-H; Hsu C; Lin M.-H; Huang C.-S; YEN-SHEN LU; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:51:55Z |
CYP19 genetic polymorphism haplotype aasa is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancer
|
Kuo S.-H;Yang S.-Y;Lien H.-C;Lo C;Lin C.-H;Yen-Shen Lu;Cheng A.-L;Chang K.-J;Huang C.-S.; Kuo S.-H; Yang S.-Y; Lien H.-C; Lo C; Lin C.-H; YEN-SHEN LU; Cheng A.-L; Chang K.-J; Huang C.-S. |
| 臺大學術典藏 |
2020-05-25T06:51:55Z |
Benzene-poly-carboxylic acids complex with cis-diammineplatinum (II) dichloride in the treatment of stage IV breast cancer patients
|
Dewi S;Larsen S;Srimuninnimit V;Yen-Shen Lu;Manuaba T;Lindk?R-Jensen S.; Dewi S; Larsen S; Srimuninnimit V; YEN-SHEN LU; Manuaba T; Lindk?r-Jensen S. |
| 臺大學術典藏 |
2020-05-25T06:51:55Z |
Distant metastasis in triple-negative breast cancer
|
Chang H.K; Chao T.C; Ouyang F; Hou M.F.; Lin Y.C; Li H; Chang D.Y; Lin C.H; YEN-SHEN LU; Chen S.C; Hsu N.C; Tseng L.M; Tseng L.M;Hsu N.C;Chen S.C;Yen-Shen Lu;Lin C.H;Chang D.Y;Li H;Lin Y.C;Chang H.K;Chao T.C;Ouyang F;Hou M.F. |
| 臺大學術典藏 |
2020-05-25T06:51:55Z |
Distinct clinicopathological features and prognosis of emerging young-female breast cancer in an east Asian country: A nationwide cancer registry-based study
|
Lin C.-H;Chuang P.-Y;Chiang C.-J;Yen-Shen Lu;Cheng A.-L;Kuo W.-H;Huang C.-S;Lai M.-S;You S.-L;Tang C.-H.; Lin C.-H; Chuang P.-Y; Chiang C.-J; YEN-SHEN LU; Cheng A.-L; Kuo W.-H; Huang C.-S; Lai M.-S; You S.-L; Tang C.-H. |
| 臺大學術典藏 |
2020-05-25T06:51:54Z |
Quantification of target analytes in various biofluids using a postcolumn infused-internal standard method combined with matrix normalization factors in liquid chromatography-electrospray ionization mass spectrometry
|
Liao H.-W;Tsai I.-L;Chen G.-Y;Yen-Shen Lu;Lin C.-H;Kuo C.-H.; Liao H.-W; Tsai I.-L; Chen G.-Y; YEN-SHEN LU; Lin C.-H; Kuo C.-H. |
| 臺大學術典藏 |
2020-05-25T06:51:54Z |
Differential expression of hyaluronan synthase 2 in breast carcinoma and its biological significance
|
Lien H.-C;Lee Y.-H;Jeng Y.-M;Lin C.-H;Yen-Shen Lu;Yao Y.-T.; Lien H.-C; Lee Y.-H; Jeng Y.-M; Lin C.-H; YEN-SHEN LU; Yao Y.-T. |
| 臺大學術典藏 |
2020-05-25T06:51:54Z |
No increased venous thromboembolism risk in Asian breast cancer patients receiving adjuvant tamoxifen
|
Chen T.W.-W;Chen H.-M;Lin C.-H;Huang C.-S;Cheng A.-L;Lai M.-S;Yen-Shen Lu; Chen T.W.-W; Chen H.-M; Lin C.-H; Huang C.-S; Cheng A.-L; Lai M.-S; YEN-SHEN LU |
| 臺大學術典藏 |
2020-05-25T06:51:54Z |
A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Lin C.-C;Su W.-C;Yen C.-J;Hsu C.-H;Su W.-P;Yeh K.-H;Yen-Shen Lu;Cheng A.-L;Huang D.C.-L;Fritsch H;Voss F;Taube T;Yang J.C.-H.; Lin C.-C; Su W.-C; Yen C.-J; Hsu C.-H; Su W.-P; Yeh K.-H; YEN-SHEN LU; Cheng A.-L; Huang D.C.-L; Fritsch H; Voss F; Taube T; Yang J.C.-H. |
| 臺大學術典藏 |
2020-05-25T06:51:53Z |
High prevalence of the BIM deletion polymorphism in young female breast cancer in an East Asian country
|
Lin C.-H;Shen C.-Y;Lee J.-H;Huang C.-S;Yang C.-H;Kuo W.-H;Chang D.-Y;Hsiung C.-N;Kuo K.-T;Chen W.-W;Chen I.-C;Wu P.-F;Kuo S.-H;Chen C.-J;Yen-Shen Lu;Cheng A.-L.; Lin C.-H; Shen C.-Y; Lee J.-H; Huang C.-S; Yang C.-H; Kuo W.-H; Chang D.-Y; Hsiung C.-N; Kuo K.-T; Chen W.-W; Chen I.-C; Wu P.-F; Kuo S.-H; Chen C.-J; YEN-SHEN LU; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:51:53Z |
Bevacizumab preconditioning followed by etoposide and cisplatin is highly effective in treating brain metastases of breast cancer progressing from whole-brain radiotherapy
|
Shih T.T.-F; Cheng A.-L; Taiwan Breast Cancer Consortium; Huang C.-S; Huang S.-M; Chao T.-C; Chen B.-B; Rau K.-M; Wu P.-F; Tseng L.-M; Yeh D.-C; Lin C.-H; Chen T.W.-W; YEN-SHEN LU; Taiwan Breast Cancer Consortium;Cheng A.-L;Shih T.T.-F;Huang C.-S;Huang S.-M;Chao T.-C;Chen B.-B;Rau K.-M;Wu P.-F;Tseng L.-M;Yeh D.-C;Lin C.-H;Chen T.W.-W;Yen-Shen Lu |
| 臺大學術典藏 |
2020-05-25T06:51:53Z |
A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis
|
Wu P.-F; Lin C.-H; Kuo C.-H; Chen W.-W; Yeh D.-C; Liao H.-W; Huang S.-M; Cheng A.-L; YEN-SHEN LU; Wu P.-F;Lin C.-H;Kuo C.-H;Chen W.-W;Yeh D.-C;Liao H.-W;Huang S.-M;Cheng A.-L;Yen-Shen Lu |
| 臺大學術典藏 |
2020-05-25T06:51:52Z |
TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays
|
Lin C.-H;Chen I.-C;Huang C.-S;Hu F.-C;Kuo W.-H;Kuo K.-T;Wang C.-C;Wu P.-F;Chang D.-Y;Wang M.-Y;Chang C.-H;Chen W.-W;Yen-Shen Lu;Cheng A.-L.; Lin C.-H; Chen I.-C; Huang C.-S; Hu F.-C; Kuo W.-H; Kuo K.-T; Wang C.-C; Wu P.-F; Chang D.-Y; Wang M.-Y; Chang C.-H; Chen W.-W; YEN-SHEN LU; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:51:52Z |
Associations between medical conditions and breast cancer risk in asians: A nationwide population-based study in Taiwan
|
Chuang S.-C;Wu G.-J;Yen-Shen Lu;Lin C.-H;Hsiung C.A.; Chuang S.-C; Wu G.-J; YEN-SHEN LU; Lin C.-H; Hsiung C.A. |
| 臺大學術典藏 |
2020-05-25T06:51:52Z |
Evaluation of the treatment response to neoadjuvant chemotherapy in locally advanced breast cancer using combined magnetic resonance vascular maps and apparent diffusion coefficient
|
Chang Y.-C.;Chen J.-Y;Chen H.-H;Yen-Shen Lu;Huang C.-S;Chang R.-F;Wu L.-A; Wu L.-A; Chang R.-F; Huang C.-S; YEN-SHEN LU; Chen H.-H; Chen J.-Y; Chang Y.-C. |
| 臺大學術典藏 |
2020-05-25T06:51:51Z |
Tailor the adjuvant hormonal manipulation for premenopausal breast cancer patients
|
Chen T.W.-W;Lin C.-H;Yen-Shen Lu; Chen T.W.-W; Lin C.-H; YEN-SHEN LU |
| 臺大學術典藏 |
2020-05-25T06:51:51Z |
Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer
|
Lin P.-H;Kuo W.-H;Huang A.-C;Yen-Shen Lu;Lin C.-H;Kuo S.-H;Wang M.-Y;Liu C.-Y;Cheng F.T.-F;Yeh M.-H;Li H.-Y;Yang Y.-H;Hsu Y.-H;Fan S.-C;Li L.-Y;Yu S.-L;Chang K.-J;Chen P.-L;Ni Y.-H;Huang C.-S.; Lin P.-H; Kuo W.-H; Huang A.-C; YEN-SHEN LU; Lin C.-H; Kuo S.-H; Wang M.-Y; Liu C.-Y; Cheng F.T.-F; Yeh M.-H; Li H.-Y; Yang Y.-H; Hsu Y.-H; Fan S.-C; Li L.-Y; Yu S.-L; Chang K.-J; Chen P.-L; Ni Y.-H; Huang C.-S. |
| 臺大學術典藏 |
2020-05-25T06:51:50Z |
Luteal versus follicular phase surgical oophorectomy plus tamoxifen in premenopausal women with metastatic hormone receptor-positive breast cancer
|
Love R.R;Hossain S.M;Hussain Md.M;Mostafa M.G;Laudico A.V;Siguan S.S.S;Adebamowo C;Sun J.-Z;Fei F;Shao Z.-M;Liu Y;Akram Hussain S.Md;Zhang B;Cheng L;Panigaro S;Walta F;Chuan J.H;Mirasol-Lumague M.R;Yip C.-H;Navarro N.S;Jr;Huang C.-S;Yen-Shen Lu;Ferdousy T;Salim R;Akhter C;Nahar S;Uy G;Young G.S;Hade E.M;Jarjoura D.; Love R.R; Hossain S.M; Hussain Md.M; Mostafa M.G; Laudico A.V; Siguan S.S.S; Adebamowo C; Sun J.-Z; Fei F; Shao Z.-M; Liu Y; Akram Hussain S.Md; Zhang B; Cheng L; Panigaro S; Walta F; Chuan J.H; Mirasol-Lumague M.R; Yip C.-H; Navarro N.S; Jr; Huang C.-S; YEN-SHEN LU; Ferdousy T; Salim R; Akhter C; Nahar S; Uy G; Young G.S; Hade E.M; Jarjoura D. |
